Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease (Q44797986)

6 December 2017

title

Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

6 December 2017

0 references

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

inflammatory bowel diseases

1 reference

based on heuristic

inferred from title

author name string

Achuthan Sourianarayanane

1

1 reference

6 December 2017

Gaurav Garg

2

1 reference

6 December 2017

Thomas H Smith

3

1 reference

6 December 2017

Mujtaba I Butt

4

1 reference

6 December 2017

Arthur J McCullough

5

1 reference

6 December 2017

Bo Shen

6

1 reference

6 December 2017

publication date

15 November 2012

1 reference

Journal of Crohn's and Colitis

6 December 2017

published in

1 reference

6 December 2017

volume

7

1 reference

6 December 2017

issue

8

1 reference

6 December 2017

page(s)

e279-85

1 reference

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Mundane, yet challenging: the assessment of malnutrition in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Fatty liver: imaging patterns and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Mechanisms and Implications of Age-Related Changes in the Liver: Nonalcoholic Fatty Liver Disease in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Other disease associations with non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Post-jejunoileal-bypass Hepatic Disease: Its Similarity to Alcoholic Hepatic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Liver structure and function following small bowel resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.10.015

10.1016/J.CROHNS.2012.10.015

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference